The global colorectal cancer therapeutics market was valued at USD 11.5 billion in 2022 and is projected to reach USD 13.9 billion in 2026 and USD 16.7 billion by 2030, expanding at a CAGR of 4.7% from 2023 to 2030. Market growth is driven by the increasing prevalence of colorectal cancer, advancements in cancer screening and diagnostics, the introduction of targeted therapies, and growing...